The document evaluates clinical pathway reports from April to December 2016 for the clinical pathway of bronchopneumonia. It provides data on the number of patient medical records reviewed each month, and the percentage that followed the clinical pathway. The percentage that followed the pathway ranged from 6.6% to 25% over the months evaluated.
The document evaluates clinical pathway reports from April to December 2016 for the clinical pathway of bronchopneumonia. It provides data on the number of patient medical records reviewed each month, and the percentage that followed the clinical pathway. The percentage that followed the pathway ranged from 6.6% to 25% over the months evaluated.
The document evaluates clinical pathway reports from April to December 2016 for the clinical pathway of bronchopneumonia. It provides data on the number of patient medical records reviewed each month, and the percentage that followed the clinical pathway. The percentage that followed the pathway ranged from 6.6% to 25% over the months evaluated.